Salt Rock Capital Partners LLP and Salt Rock Master Fund Limited filed a Schedule 13G with the SEC on November 10, 2026, disclosing a combined beneficial ownership of 110,627 shares of ENDRA Life Sciences Inc. common stock, representing 7.4% of the class as of September 30, 2026.

Key Highlights

  • Aggregate beneficial ownership: Salt Rock Capital Partners LLP and Salt Rock Master Fund Limited each report beneficial ownership of 110,627 shares of ENDRA Life Sciences common stock.
  • Percent of class: The 110,627 shares represent 7.4% of the outstanding class of common stock, according to the filing.
  • Shared voting and dispositive power: Both reporting persons report 0 shares with sole voting or sole dispositive power; all 110,627 shares are held with shared voting and shared dispositive power.
  • Event date: The date of the event requiring the filing is listed as September 30, 2026.
  • Reporting persons: Salt Rock Capital Partners LLP is organized in the United Kingdom; Salt Rock Master Fund Limited is organized in the Cayman Islands.
  • Signatories: Frederick Short, Vice President of Salt Rock Capital Partners LLP, and Olive Gibson, Fund Director of Salt Rock Master Fund Limited, signed the filing on November 10, 2026.

Salt Rock Capital's Disclosed Position in ENDRA Life Sciences Common Stock

Salt Rock Capital Partners LLP and Salt Rock Master Fund Limited jointly filed a Schedule 13G disclosing their ownership of common stock in ENDRA Life Sciences Inc. (NASDAQ:NDRA), whose principal executive offices are located at 3600 Green Court, Suite 350, Ann Arbor, Michigan 48105. The filing covers common stock with CUSIP number 29273B500. The triggering event date is reported as September 30, 2026, and the statement was filed on November 10, 2026.

According to the filing, each of the two reporting persons beneficially owns 110,627 shares, amounting to 7.4% of the class. Neither reporting person holds any sole voting power or sole dispositive power over the shares; both the voting power and dispositive power over all 110,627 shares are classified as shared between the two entities. Salt Rock Capital Partners LLP is identified as a United Kingdom entity with its principal office at 21 Arlington Street, London, SW1A 1RN. Salt Rock Master Fund Limited is a Cayman Islands entity, with its registered address at Walkers Corporate Limited, 190 Elgin Avenue, George Town, Cayman Islands, KY1-9008.

The filing certifies, in the words of the signatories, that "the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer." Both reporting persons are classified as type "FI" in the Schedule 13G header sections, and the filing also notes classifications of "IA, IV" under Item 3.

What Was Disclosed

Salt Rock Capital Partners LLP and Salt Rock Master Fund Limited disclosed a combined beneficial ownership of 110,627 shares, equal to 7.4% of ENDRA Life Sciences Inc. common stock, with all shares held under shared voting and shared dispositive power as of September 30, 2026.